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Synthesis of 2,6-trans- and 3,3,6-trisubstituted
tetrahydropyran-4-ones from Maitland–Japp
derived 2H-dihydropyran-4-ones: a total
synthesis of diospongin B†
Paul A. Clarke,* Nadiah Mad Nasir, Philip B. Sellars, Alejandra M. Peter,
Connor A. Lawson and James L. Burroughs
6-Substituted-2H-dihydropyran-4-one products of the Maitland–Japp reaction have been converted into
tetrahydropyrans containing uncommon substitution patterns. Treatment of 6-substituted-2H-dihydro-
pyran-4-ones with carbon nucleophiles led to the formation of tetrahydropyran rings with the 2,6-trans-
stereochemical arrangement. Reaction of the same 6-substituted-2H-dihydropyran-4-ones with L-Selec-
tride led to the formation of 3,6-disubstituted tetrahydropyran rings, while trapping of the intermediate
enolate with carbon electrophiles in turn led to the formation 3,3,6-trisubstituted tetrahydropyran rings.
The relative stereochemical conﬁguration of the new substituents was controlled by the stereoelectronic
preference for pseudo-axial addition of the nucleophile and trapping of the enolate from the opposite
face. Application of these methods led to a synthesis of the potent anti-osteoporotic diarylheptanoid
natural product diospongin B.
Introduction
Substituted tetrahydropyran (THP) rings are present in a large
number of biologically active natural products, and as such
their synthesis has received much attention over the years.1,2
On inspection of these THP rings it is clear that some substi-
tution patterns occur more often than others, and this has
resulted in a greater amount of synthetic eﬀort being directed
towards their synthesis compared to the synthesis of other
substitution patterns. The consequences of those eﬀorts are
that these common substitution patterns can now be accessed
readily, while the more uncommon substitution patterns still
require greater synthetic eﬀort. For example, 2,6-cis-THP rings
can be accessed by a wide variety of methods, including
thermodynamically controlled oxy-Michael reactions,3,4 Diels–
Alder reactions,5 Prins rearrangements,6,7 reduction of cyclic
oxocarbenium ions,8 metal mediated cyclisations9 and the
Maitland–Japp reaction.10 Conversely, construction of the 2,6-
trans-THP ring is almost exclusively limited to either nucleo-
philic addition to cyclic hemiacetals via an oxocarbenium
ion11,12 or kinetically controlled oxy-Michael reactions,3,4
though in the latter case the trans-selectivity is often only
moderate.
A survey of THP-containing natural products shows that a
sizable number do contain the 2,6-trans-THP ring, for example
psymberin13 (an inhibitor of cancer cell proliferation), zinco-
phorin14 (an antibiotic), aspergillide B15 (cytotoxicity against
mouse lymphocytic leukemia cells) and diospongin B16 (anti-
osteoporotic activity) (Fig. 1).
Fig. 1 2,6-trans-Tetrahydropyran-containing natural products.
†Electronic supplementary information (ESI) available: Spectroscopic data for all
compounds synthesised. See DOI: 10.1039/c6ob01182a
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We recently reported the synthesis of substituted dihydro-
pyran-4-ones (DHPs), by extension of the Maitland–Japp reac-
tion,17 a method which is complementary to the Diels–Alder
route popularised by Danishfesky.18 We then converted these
DHPs into 2,6-cis-THPs.17 This strategy enabled us to complete
syntheses of “Civet” and a fully functionalised model A-ring of
lasonolide A. Given the dearth of methods for the construction
of 2,6-trans-THP rings we turned our attention to the develop-
ment of a new method for the selective synthesis of 2,6-trans-
THPs. We envisaged that 2,6-trans-THPs could be formed from
the conjugate addition of a carbon nucleophile to the double
bond of Maitland–Japp DHPs such as 5. We rationalised that
the stereoelectronic preference for axial addition of a nucleo-
phile to the double bond would generate a 2,6-trans-THP with
the opportunity to trap the resultant enolate, which would
allow for further functionalisation of the THP-ring (Fig. 2).
Results and discussion
Synthesis of dihydropyran-4-ones
In order to investigate the formation of 2,6-trans-THPs we had
to prepare DHPs 5. To this end we employed the conditions we
had used for the synthesis of C2-substituted DHPs (an ortho-
amide or orthoester in toluene),17 however, when we used the
dimethyl acetal of N,N-dimethylformamide and δ-hydroxy-
β-ketoesters 7, complex mixtures of products resulted. Our
initial results suggested that there was an inherent instability
in the DHPs 5 that was not apparent in their C2-substituted
counterparts, this was particularly noticeable during
attempted isolation by chromatography on silica gel (2D TLC
showed multiple interconverting spots). However, if the crude
reaction mixture was exposed to a Gilman cuprate, it was poss-
ible to isolate some 2,6-trans THP – with the exception of 7a
which gave a moderate isolated yield of DHP 5a. Following
considerable investigation we realised that the Knoevenagel-
like condensation of the orthoamide occurred but the oxy-
Michael cyclisation to give the DHP did not. This issue could
be rectified by performing the reaction with only one equi-
valent of orthoamide in CH2Cl2, rather than PhMe, followed by
the addition of BF3·OEt2 to promote cyclisation, resulting in a
92% crude mass balance of 5a which could be used crude,
without the need for purification (Scheme 1).
These conditions proved general for the synthesis of a
range of C2-unsubstituted, C6-substituted DHPs 5 (Table 1). In
addition to the 2-furyl group 5a, other heteroaromatic substitu-
ents could be incorporated 5h, as well as phenyl 5b. n-Alkyl
and branched alkyl substituents are readily tolerated 5c and
5d, along with alkene-containing side chains 5f and 5g.
Perhaps the most encouraging, as it allows further elaboration
of the C6-side chain, is the realisation that TIPS-protected alco-
hols can also be incorporated 5e.
With a range of DHPs to hand we were now in a position to
study to formation of 2,6-trans-substituted THPs.
Conversion of dihydropyran-4-ones to 2,6-trans-
tetrahydropyran-4-ones
When DHPs 5 were treated with a range of Gilman cuprates,
Ph2CuLi, Me2CuLi and Bu2CuLi in the presence of TMSCl at
−78 °C in THF, it was found that conjugate addition occurred
smoothly to yield the 2,6-trans-THPs in a mixture of enol and
keto-forms 8/9 (Table 2). Addition of Ph2CuLi generated the
2,6-trans-THPs exclusively as the enol tautomer 8. However,
use of Me2CuLi and Bu2CuLi generated mixtures of enol–keto
tautomers 8 and 9 of the 2,6-trans-THPs. For the purposes of
characterisation, these tautomers were converted into enol
acetates 10 by the action of Ac2O, pyridine and DMAP.
We rationalise that 2,6-trans-THPs exist as a mixture of
keto/enol tautomers because either the C2 or C6 substituent
must be axial. The penalty for having an axial substituent may
Fig. 2 Stereoelectronic preference for axial addition of nucleophiles
leading to 2,6-trans-THPS.
Scheme 1 Formation of C2-unsubstituted DHPs.
Table 1 Synthesis of DHPs
DHP 5 R
Crude mass
balance (%)
a 2-Furyl 92
b Ph 96
c Pr 91
d i-Pr 97
e CH2OTIPS 88
f CHvCHCH3 87
g CHvCHPh 97
h 2-Methyloxazole 77
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be partly relieved by enolisation as this allows for the for-
mation of an intramolecular H-bond and the reduction of a
1,3-diaxial interaction for the axial group. Therefore, in order
to definitively characterise the 2,6-trans-THP products the
keto/enol mixture was treated with Ac2O, pyridine and DMAP
to form enol acetates 10, where the 2,6-trans-THP stereochemi-
cal configuration was confirmed by analysis of the 1H NMR
and NOE data (Fig. 3). In the representative case of 10h there
was a strong NOE correlation between C2 methyl group and
H6 of 2.3% and a NOE correlation between C2 methyl group
and H5α of 1.86%.
Conversion of dihydropyran-4-ones to 3,6-disubstituted and
3,3,6-trisubstituted tetrahydropyran-4-ones
With the development of a successful strategy for the synthesis
of 2,6-trans-THPs we sought to extend the scope for the conver-
sion of DHPs 5 into THPs with other substitution patterns. We
considered the possibility that 3,6-disubstituted-THPs could
be accessed by the conjugate reduction of the C2–C3 double
bond. When DHPs 5 were treated with L-Selectride at −78 °C
and quenched, a range of 3,6-disubstituted THPs 11 were
formed in good yields; the enol tautomer was the major
product in all cases, with small amounts of the keto-tautomer
present. In order to aid characterisation the product mixture
was converted into the enol acetate 12 by the action of Ac2O,
pyridine and DMAP (Table 3). In all cases studied we could not
detect products from reduction of either the ketone or the
ester carbonyl groups.
The addition of L-Selectride to DHPs 5 initially generated an
enolate which was quenched upon workup to give 3,6-di-
substituted THPs 11. We wondered if it would be possible to
intercept the enolate with a carbon electrophile to form 3,3,6-
trisubstituted THPs. Alkyl halides methyl iodide, allyl bromide
and benzyl bromide were investigated (Table 4).
We reasoned that delivery of hydride would occur from the
pseudo-axial trajectory and the electrophilic quenching would
occur from the opposite face of the THP ring. This should
deliver THP products with a quaternary stereocenter at C3, in
which the R and R1 groups are cis to each other. No other dia-
stereomer was detected in the 1H NMR of the crude reaction
mixture. The THP products 13 were characterised, and the rela-
tive stereochemical configuration confirmed, by 1H NMR and
NOE correlations. For example, in the representative case of
13i there was a clear NOE of 3.6% between H6 and H5α when
H6 was irradiated. When H5α was irradiated a NOE to H6 of
2.26% was seen. There was a NOE of 3.16% between H5β and
the benzyl CH2 group, indicating that these were both axial
(Fig. 4). The protocol gave the desired functionalisation with
the halide electrophiles but, to our disappointment, we were
unable to intercept the enolate with aldehyde electrophiles,
Table 2 Synthesis of 2,6-trans-THPs
THP R R1 Ratioa 8 : 9
Yieldb 8/9
(%)
Yieldb 10
(%)
a Ph Ph 1 : 0 70 N/A
b Pr Ph 1 : 0 56 N/A
c i-Pr Ph 1 : 0 73 N/A
d CH2OTIPS Ph 1 : 0 48 N/A
e CHvCHCH3 Ph 1 : 0 64 N/A
f CHvCHPh Ph 1 : 0 91 N/A
g 2-furyl Me 1 : 0.4 50 82
h Ph Me 1 : 0.2 64 74
i Pr Me 1 : 0.4 64 64
j i-Pr Me 1 : 0.3 88 77
k CH2OTIPS Me 1 : 0.4 76 81
l CHvCHCH3 Me 1 : 0.5 53 56
m Ph Bu 1 : 0.3 82 48
n Pr Bu 1 : 0.5 58 62
o i-Pr Bu 1 : 0.2 48 79
p CH2OTIPS Bu 1 : 0.5 24 70
a Ratio obtained by integration of H-3 and OH resonances in the 1H
NMR of the crude reaction mixture. b Isolated yield after column
chromatography.
Fig. 3 NOE correlations conﬁrming the 2,6-trans-stereochemical
conﬁguration of 10h. Table 3 Synthesis of 3,6-disubstituted-THPs
DHP 5 R
Yielda 11
(%)
Ratioa,b
enol : keto
Yielda 12
(%)
a 2-Furyl 44 1 : 0.4 58
b Ph 74 1 : 0.2 68
c Pr 89 1 : 0.2 51
e CH2OTIPS 65 1 : 0.2 65
g CHvCHPh 51 1 : 0.4 56
a After flash column chromatography. bDetermined by integration of
the 1H NMR.
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which probably reflects the inherent stability of the β-keto-
ester’s enolate anion.
Synthesis of diospongin B
With procedures developed for the synthesis of highly substi-
tuted THP-rings, especially the less common and synthetically
more challenging 2,6-trans-THP, we sought to demonstrate the
utility of the approach by completing the total synthesis of the
anti-osteoporotic 2,6-trans-THP-containing natural product
diospongin B 2. Diospongin B is a diaryl heptanoid natural
product which was isolated in 2003 from the rhizomes of
Dioscorea spongiosa and was shown to exhibit potent inhibitory
activity on bone resorption induced by parathyroid hormone.16
The activity of diospongin B is comparable to calcitonin, a
drug currently used to treat osteoporosis, and this has led to a
number of total syntheses being reported for it and its 2,6-cis-
diastereomer, diospongin A.19
Our synthesis (Scheme 2) began with the Maitland–Japp
formation of DHP 5g in 97% yield using the dimethylacetal of
N,N-dimethyl formamide. Conjugate addition of Ph2CuLi to 5g
yielded 2,6-trans-THP 8f in 91%. Microwave-mediated decar-
boxylation in wet DMF generated the desired tetrahydropyran-
4-one,20 which was in turn reduced with L-Selectride to give
THP 14 as the major diastereomer (9 : 1) with the correct rela-
tive stereochemical configuration for diospongin B. The stereo-
chemical configuration of 14 was confirmed by H2 being
coupled to both H3α and H3β with J = 4.4 Hz indicating its
equatorial position, H6 was coupled to H5β J = 9.1 Hz and H5α
J = 5.0 Hz, indicating its axial position while H4 was coupled
to H5β J = 9.3 Hz, H5α J = 4.5 Hz, H3β J = 9.0 Hz and H3α J =
4.0 Hz indicating its axial orientation. Additionally, H2 only
had NOE correlations to H3α of 1.33% and to H3β of 1.89%,
H4 had NOE correlations to H6 of 1.23%, to H3α of 1.58% and
to H5α of 2.59% (Fig. 5). The synthesis was completed by
MOM-protection of the free hydroxyl in 60% yield, and Wacker
oxidation of the double bond to give 15 in 70% yield.19f The
final step was the removal of the MOM protecting group,
which was achieved by the action of aqueous HCl19f and gener-
ated diospongin B 2 in 58% yield. Spectroscopic data for our
sample of diospongin B 2 were identical to those reported in
the literature.19
Table 4 Synthesis of 3,3,6-trisubstituted THPs
THP 13 R R1 Yield
a 13 (%)
a Ph Me 59
b CHvCHPh Me 53
c CH2OTIPS Me 57
d Pr Me 58
e Ph CH2CHvCH2 52
f CHvCHPh CH2CHvCH2 83
g CH2OTIPS CH2CHvCH2 57
h Pr CH2CHvCH2 52
i Ph Bn 65
j CHvCHPh Bn 51
k CH2OTIPS Bn 62
l Pr Bn 62
a Isolated yield after column chromatography.
Fig. 4 NOE correlations and coupling constants conﬁrming the stereo-
chemical conﬁguration of 13i.
Scheme 2 Synthesis of Diospongin B.
Fig. 5 NOE correlations and coupling constants conﬁrming the stereo-
chemical conﬁguration of 14.
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Conclusions
We have developed a modification of the Maitland–Japp reac-
tion using orthoamides which provides access to a range of
6-substituted-2H-dihydropyran-4-ones in good yields. These
2H-dihydropyran-4-ones can be converted into tetrahydropyran
products with uncommon substitution patterns which are
found in a number of biologically active natural products. 2,6-
trans-Tetrahydropyran-4-ones are obtained by the stereo-
selective addition of Gilman cuprates to 6-substituted-2H-di-
hydropyran-4-ones. Tetrahydropyrans with the 3,6-substitution
pattern are accessed by the conjugate addition of L-Selectride,
while 3,3,6-substitution pattern are obtained by trapping the
enolate formed on addition of L-Selectride with a carbon elec-
trophile. The utility of these procedures was demonstrated by
their use in the total synthesis of diospongin B, a natural
product with potent anti-osteoperotic activity. This work pro-
vides a new route to uncommon tetrahydropyran substitution
patterns and may ease the synthesis of a significant number of
natural products containing these units.
Experimental
General methods
Thin layer chromatography was performed on aluminium
plates coated with Merck silica gel 60 F254. The plates were
developed using ultraviolet light, acidic aqueous ceric
ammonium molybdate, basic aqueous potassium permanga-
nate or ethanolic anisaldehyde. Flash column chromatography
was performed with the solvent systems indicated in the
appropriate experimental procedure. The stationary phase was
silica gel 60 (220–240 mesh), unless stated otherwise. Dichloro-
methane was distilled from calcium hydride; THF and Et2O
were distilled from sodium–benzophenone ketyl radical;
toluene was dried over sodium wire; hexane was distilled prior
to use. All other solvents and reagents were used as received
from commercial suppliers. 1H NMRs were recorded at
ambient temperature at either 400 MHz or 500 MHZ and
13C NMRs were recorded at ambient temperature at either
100 MHz or 125 MHz. Mass spectrometry was performed using
ES ionisation.
General procedure for the synthesis of 6-substituted-
2H-dihydropyran-4-ones 5
N,N-Dimethylformamide dimethyl acetal (0.03 mL, 0.20 mmol)
was added to a stirred solution of δ-hydroxy-β-ketoester 7
(0.2 mmol) in dry dichloromethane (2 mL) at room tempera-
ture. After stirring at this temperature for 45 minutes, BF3·OEt2
(0.03 mL, 0.20 mmol) was added. The reaction was stirred at
room temperature and monitored by TLC (hexane–ethyl
acetate). Upon completion the mixture was diluted with EtOAc
(40.0 mL) and washed with sat. aq. NaHCO3 (10.0 mL). The
aqueous layer was extracted with EtOAc (15.0 mL) and the com-
bined organic extracts were washed with brine (10.0 mL), dried
over MgSO4 and concentrated in vacuo to give the crude DHP
5. No further purification was carried out on the products and
they were used crude in all subsequent reactions.
Methyl 2-(furan-2-yl)-4-oxo-3,4-dihydro-2H-pyran-5-carb-
oxylate 5a. δ-Hydroxy-β-ketoester 7a (0.698 g, 3.292 mmol),
yielded 0.674 g (92%), light yellow oil. ν max/cm−1 2953, 1738,
1704, 1579, 1436, 1383, 1296, 1133, 1013, 816, 732 cm−1; δH
(400 MHz, CDCl3) 8.27 (1H, s), 7.44 (1H, dd, J = 1.8, 0.6 Hz),
6.45 (1H, d, J = 3.3 Hz), 6.36 (1H, dd, J = 3.3, 1.8 Hz), 5.58 (1H,
dd, J = 11.5, 4.3 Hz), 3.74 (3H, s), 3.07 (1H, dd, J = 16.6,
11.5 Hz) and 2.79 (1H, dd, J = 16.6, 4.3 Hz) ppm; δC (100 MHz,
CDCl3) 186.8, 170.5, 170.4, 163.8, 148.7, 143.9, 110.8, 110.6,
74.7, 51.9 and 39.3 ppm; m/z (ESI+) 245 (M + Na)+, 223 (M + H)+,
(Found 245.0423 (M + Na)+. C11H10NaO5 requires; 245.0426).
Methyl 4-oxo-2-phenyl-3,4-dihydro-2H-pyran-5-carboxylate
5b. δ-Hydroxy-β-ketoester 7b (0.050 g, 0.204 mmol), yielded
0.045 g (96%), orange solid. ν max/cm−1 2955, 1738, 1661,
1572, 1372, 1290, 1244, 1146, 1047, 845, 761, 698, 500 cm−1;
δH (400 MHz, CDCl3) 8.43 (1H, s), 7.43–7.36 (5H, m), 5.54 (1H,
dd, J = 12.0, 4.0 Hz), 3.81 (3H, s), 2.96 (1H, dd, J = 16.0, 4.0 Hz)
and 2.76 (1H, d, J = 16.0, 4.0 Hz) ppm; δC (100 MHz, CDCl3)
186.8, 171.3, 164.2, 136.9, 129.4, 129.0, 126.2, 111.2, 82.3, 52.1
and 43.1 ppm; m/z (ESI+) 255 (M + Na)+, 233 (M + H)+, (Found
255.0631 (M + Na)+. C13H12NaO4 requires; 255.0633).
Methyl 4-oxo-2-propyl-3,4-dihydro-2H-pyran-5-carboxylate 5c.
δ-Hydroxy-β-ketoester 7c (0.052 g, 0.276 mmol), yielded 0.049 g
(91%), light yellow oil. ν max/cm−1 2958, 2874, 1741, 1700,
1582, 1435, 1380, 1300, 1147, 1074, 799, 506 cm−1; δH
(400 MHz, C6D6) 7.97 (1H, s), 3.71–3.64 (1H, m), 3.52 (3H, s),
1.97 (1H, dd, J = 16.2, 4.1 Hz), 1.89 (1H, dd, J = 16.2, 12.4 Hz),
1.24–0.98 (2H, m), 0.98–0.86 (2H, m) and 0.64 (3H, t, J =
7.2 Hz) ppm; δC (100 MHz, C6D6) 187.6, 171.5, 164.5, 116.9,
81.3, 51.9, 41.6, 36.0, 17.9 and 13.7 ppm; m/z (ESI+) 221
(M + Na)+, 199 (M + H)+, (Found 221.0782 (M + Na)+.
C10H14NaO4 requires; 221.0790).
Methyl 2-isopropyl-4-oxo-3,4-dihydro-2H-pyran-5-carboxylate
5d. δ-Hydroxy-β-ketoester 7d (0.750 g, 3.780 mmol), yielded
0.713 g (88%), light yellow oil. ν max/cm−1 2962, 1741, 1699,
1633, 1583, 1435, 1383, 1295, 1122, 1047, 771, 593 cm−1; δH
(400 MHz, CDCl3) 8.33 (1H, s), 4.28–4.22 (1H, m), 3.76 (3H, s),
2.55 (1H, dd, J = 16.3, 13.6 Hz), 2.46 (1H, dd, J = 16.3, 3.8 Hz),
2.05–1.97 (1H, m), 0.97 (3H, d, J = 6.8 Hz) and 0.99 (3H, d, J =
6.8 Hz) ppm; δC (100 MHz, CDCl3) 187.8, 171.8, 164.2, 110.6,
85.7, 51.9, 39.0, 31.7, 17.8 and 17.6 pm; m/z (ESI+) 221
(M + Na)+, 199 (M + H)+, (Found 221.0786 (M + Na)+.
C10H14NaO4 requires; 221.0790).
Methyl 4-oxo-2-(((triisopropylsilyl)oxy)methyl)-3,4-dihydro-
2H-pyran-5-carboxylate 5e. δ-Hydroxy-β-ketoester 7e (0.033 g,
0.099 mmol), yielded 0.029 g (88%), light orange oil.
ν max/cm−1 2953, 1738, 1704, 1579, 1436, 1383, 1296, 1133,
1013, 816, 732 cm−1; δH (400 MHz, C6D6) 7.99 (1H, s),
3.81–3.75 (1H, m), 3.49 (3H, s), 3.29–3.25 (1H, m), 2.42 (1H,
dd, J = 16.2, 13.0 Hz), 2.07 (1H, dd, J = 16.2, 3.8 Hz) and
1.10–9.94 (21H, m) ppm; δC (100 MHz, C6D6) 187.4, 171.4,
164.3, 110.6, 81.5, 64.2, 52.0, 38.2, 17.9 and 11.9 ppm; m/z
(ESI+) 365 (M + Na)+ (Found 365.1741 (M + Na)+. C17H30NaO5Si
requires; 365.1760).
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Methyl 4-oxo-2-(prop-1-en-1-yl)-3,4-dihydro-2H-pyran-5-carb-
oxylate 5f. δ-Hydroxy-β-ketoester 7f (0.300 g, 1.612 mmol),
yielded 0.274 g (87%), light orange oil. ν max/cm−1 2952, 2919,
1740, 1701, 1579, 1435, 1380, 1297, 1135, 1053, 965 cm−1;
δH (400 MHz, CDCl3) 8.01 (1H, s), 5.28 (1H, m), 5.08 (1H, m),
4.20 (1H, ddd, J = 8.6, 7.0, 7.0 Hz), 3.51 (3H, s), 2.08 (2H, m)
and 1.31 (3H, d, J = 6.5 d) ppm; δC (100 MHz, CDCl3) 181.2,
169.9, 164.3, 131.5, 127.0, 111.5, 80.9, 51.3, 41.8 and 17.5 ppm;
m/z (ESI+) 219 (M + Na)+ (Found 219.0629 (M + Na)+.
C10H12NaO4 requires; 219.0628).
Methyl 4-oxo-2-styryl-3,4-dihydro-2H-pyran-5-carboxylate 5g.
δ-Hydroxy-β-ketoester 7g (0.106 g, 0.427 mmol), yielded 0.107 g
(97%), orange solid. ν max/cm−1 2951, 1693, 1569, 1436, 1369,
1260, 1295, 1060, 966, 747, 692 cm−1; δH (400 MHz, CDCl3)
8.04 (1H, s), 7.10–7.03 (5H, m), 6.19 (1H, dd, J = 16.0, 1.1 Hz),
5.73 (1H, dd, J = 16.0, 6.8 Hz), 4.26 (1H, ddd, J = 9.1, 6.9,
6.8 Hz), 3.53 (3H, s) and 2.12 (2H, m) ppm; δC (100 MHz,
CDCl3) 193.2, 184.9, 169.9, 164.9, 135.6, 134.3, 128.9, 127.1,
124.2, 111.8, 81.0, 51.5 and 42.0 ppm; m/z (ESI+) 281 (M + Na)+
(Found 281.0781 (M + Na)+. C15H14NaO4 requires; 281.0784).
Methyl 2-(2-methyloxazol-4-yl)-4-oxo-3,4-dihydro-2H-pyran-
5-carboxylate 5h. δ-Hydroxy-β-ketoester 7h (0.078 g,
0.343 mmol), yielded 0.062 g (77%), light yellow oil.
ν max/cm−1 2953, 1738, 1704, 1579, 1436, 1383, 1296, 1133,
1013, 816, 732 cm−1; δH (400 MHz, CDCl3) 8.34 (1H, s), 7.61
(1H, s), 5.55 (1H, dd, J = 12.0, 4.0 Hz), 3.80 (3H, s), 3.10 (1H,
dd, J = 16.7, 12.0 Hz), 2.81 (1H, dd, J = 16.7, 4.0 Hz) and 2.48
(3H, s) ppm; δC (100 MHz, CDCl3) 198.7, 167.7, 160.1, 137.2,
63.0, 52.6, 49.6, 45.5, 31.5, 30.1 and 14.2 ppm; m/z (ESI+) 260
(M + Na)+ (Found 260.0523 (M + Na)+. C11H11NNaO5 requires;
260.0535).
General procedure for the synthesis 2,6-trans-tetrahydropyran-
4-ones 8/9
Addition of Ph2CuLi. Phenyl lithium 1.9 M in dibutyl ether
solution (0.58 mL, 0.90 mmol) was added to a suspension of
copper iodide (86.3 mg, 0.45 mmol) in THF (3.00 mL) at 0 °C.
The mixture was stirred at this temperature for 20 minutes
then cooled to −78 °C. Addition of chlorotrimethylsilane
(0.18 mL, 1.4 mmol) was followed by addition of DHP
(0.28 mmol) in THF (2.00 mL) at −78 °C. The reaction mixture
was stirred at this temperature for 30 minutes then at 0 °C for
1.5 hours. The reaction was quenched with sat. aq. NH4Cl
(2.50 mL) and allowed to warm to rt with vigorous stirring. The
mixture was diluted with sat. aq. NH4Cl (10.0 mL) and
extracted with EtOAc (5 × 15.0 mL). The combined organic
extracts were washed with H2O (15.0 mL) and brine (15.0 mL),
then dried over MgSO4 and concentrated in vacuo. Flash
column chromatography (hexane–ethyl acetate) aﬀorded the
product as a mixture of enol/keto tautomers 8/9.
(2R*,6S*)-Methyl 4-hydroxy-2,6-diphenyl-5,6-dihydro-2H-pyran-
3-carboxylate 8a. Dihydropyran 5b (0.088 g, 0.379 mmol),
yielded 0.082 g (70%), light brown oil. ν max/cm−1 (film) 2955,
2931, 2872, 1768, 1723, 1710, 1435, 1363, 1254, 1177, 1149,
1055, 875, 480 cm−1; δH (400 MHz, CDCl3) 12.4 (1H, s),
7.41–7.24 (10H, m), 5.8 (1H, s), 4.56 (1H, dd, J = 10.8, 4.0 Hz),
3.66 (3H, s), 2.73 (1H, dd, J = 18.1, 10.8 Hz), 2.59 (1H, dd, J =
18.1, 4.0 Hz) ppm; δC (100 MHz, CDCl3) 193.0, 171.2, 140.7,
128.6, 128.3, 128.0, 127.9, 126.0, 98.6, 73.3, 68.4, 51.8, 41.1,
35.6, 31.1 ppm; m/z (ESI+) 333 (M + Na)+ (Found 333.1108
(M + Na)+. C19H18NaO4 requires; 333.1103).
(2R*,6R*)-Methyl 4-hydroxy-2-phenyl-6-propyl-5,6-dihydro-
2H-pyran-3-carboxylate 8b. Dihydropyran 5c (0.045 g,
0.227 mmol), yielded 0.035 g (56%), oil. ν max/cm−1 (film)
2955, 2927, 2875, 1658, 1621, 1441, 1288, 1262, 1216, 1043,
775, 698 cm−1; δH (400 MHz, CDCl3) 12.29 (1H, s), 7.37–7.27
(5H, m), 5.59 (1H, s), 3.63 (3H, s), 3.47–3.41 (1H, m), 2.32 (1H,
dd, J = 18.0, 10.0 Hz), 2.23 (1H, dd, J = 18.0, 4.2 Hz), 1.05–1.43
(2H, m), 1.37–1.28 (2H, m) and 0.72 (3H, t, J = 7.2 Hz) ppm;
δC (100 MHz, CDCl3) 171.7, 171.2, 141.1, 128.5, 128.1, 127.8,
98.6, 72.2, 66.3, 51.7, 37.8, 35.0, 18.3 and 13.8 ppm; m/z (ESI+)
299 (M + Na)+ (Found 299.1255 (M + Na)+. C16H20NaO4
requires; 299.1254).
(2R*,6S*)-Methyl 4-hydroxy-6-isopropyl-2-phenyl-5,6-dihydro-
2H-pyran-3-carboxylate 8c. Dihydropyran 5d (0.060 g,
0.303 mmol), yielded 0.060 g (73%), light yellow oil.
ν max/cm−1 (film) 2924, 2852, 1946, 1739, 1661, 1365, 1268,
1222, 1060, 841 cm−1; δH (400 MHz, CDCl3) 12.30 (1H, s),
7.37–7.27 (5H, m), 5.62 (1H, s), 3.63 (3H, s), 3.10 (1H, dd, J =
10.8, 3.9 Hz), 2.36 (1H, dd, J = 18.0, 10.8 Hz), 2.23 (1H, dd, J =
18.0, 3.9 Hz), 1.64–1.56 (1H, m), 0.80 (3H, d, J = 6.8 Hz) and
0.77 (3H, d, J = 6.8 Hz) ppm; δC (100 MHz, CDCl3) 193.2,
141.5, 128.6, 128.0, 127.7, 98.5, 72.6, 71.6, 51.2, 41.3, 32.8,
32.3, 18.4 and 17.8 ppm; m/z (ESI+) 299 (M + Na)+ (Found
299.1245 (M + Na)+. C16H20NaO4 requires; 299.1254).
(2R*,6S*)-Methyl 4-hydroxy-2-phenyl-6-(((triisopropylsilyl)-
oxy)methyl)-5,6-dihydro-2H-pyran-3-carboxylate 8d. Dihydro-
pyran 5e (0.073 g, 0.213 mmol), yielded 0.043 g (48%), light
yellow oil. ν max/cm−1 (film) 2941, 2861, 1660, 1623, 1442,
1280, 1264, 1215, 1095, 880, 681 cm−1; δH (400 MHz, C6D6)
12.90 (1H, s), 7.38–7.36 (2H, m), 7.18–7.08 (3H, m) 5.79 (1H, s),
3.65–3.60 (1H, m), 3.55–3.46 (2H, m), 3.05 (3H, s), 2.59 (1H,
dd, J = 18.1, 10.8 Hz), 2.18 (1H, dd, J = 18.1, 2.8 Hz) and 1.01
(21H, m) ppm; δC (100 MHz, C6D6) 172.3, 171.3, 141.5, 128.9,
128.4, 127.9, 99.0, 73.1, 67.9, 66.3, 51.0, 31.4, 81.1 and
12.2 ppm; m/z (ESI+) 443 (M + Na)+ (Found 443.2209 (M + Na)+.
C23H36NaO5Si requires; 443.2224).
(2R*,6S*)-Methyl 4-hydroxy-2-phenyl-6-((E)-prop-1-en-1-yl)-
5,6-dihydro-2H-pyran-3-carboxylate 8e. Dihydropyran 5f (0.055 g,
0.280 mmol), yielded 0.049 g (64%), light yellow oil.
ν max/cm−1 (film) 3028, 2952, 2896, 1662, 1618, 1437, 1325,
1243, 1205, 1181, 1051, 958, 740, 690 cm−1; δH (400 MHz,
CDCl3) 12.30 (1H, s), 7.40–7.27 (5H, m), 5.62 (1H, s), 5.56 (1H,
d, J = 16.0, 4.0 Hz), 5.44 (1H, dd, J = 16.0, 4.0 Hz), 3.97 (1H,
ddd, J = 12.0, 4.0, 4.0 Hz), 3.62 (3H, s), 2.47 (1H, dd, J = 16.0,
12.0 Hz), 2.32 (1H, dd, J = 16.0, 4.0 Hz) and 1.65 (1H, d, J =
4.0 Hz) ppm; δC (100 MHz, CDCl3) 171.1, 140.9, 130.4, 128.6,
128.5, 128.2, 127.9, 127.1, 98.6, 73.0, 67.1, 51.6, 34.4 and
17.9 ppm; m/z (ESI+) 297 (M + Na)+ (Found 297.1091 (M + Na)+.
C16H18NaO4 requires; 297.1097).
(2R*,6S*)-Methyl 4-hydroxy-2-phenyl-6-((E)-styryl)-5,6-dihydro-
2H-pyran-3-carboxylate 8f. Dihydropyran 5g (0.988 g,
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3.829 mmol), yielded 1.170 g (91%), light yellow solid.
ν max/cm−1 (film) 3028, 2952, 2896, 1662, 1618, 1437, 1325,
1243, 1205, 1181, 1051, 958, 740, 690 cm−1; δH (400 MHz,
CDCl3) 12.32 (1H, s), 7.46–7.20 (10H, m), 6.49 (1H, d, J =
16.1 Hz), 6.15 (1H, dd, J = 16.1, 5.7 Hz), 5.70 (1H, s), 4.24 (1H,
ddd, J = 10.5, 5.7, 4.1 Hz), 3.64 (3H, s), 2.58 (1H, dd, J = 18.0,
10.5 Hz) and 2.46 (1H, dd, J = 18.0, 4.1 Hz) ppm; δC (100 MHz,
CDCl3) 171.1, 170.9, 140.8, 136.4, 131.4, 128.6, 128.5, 128.3,
128.0, 127.9, 126.6, 115.4, 98.3, 73.0, 67.4, 51.8 and 34.5 ppm;
m/z (ESI+) 359 (M + Na)+ (Found 359.1249 (M + Na)+.
C21H20NaO4 requires; 359.1254).
Addition of Me2CuLi. Methyl lithium 1.6 M in Et2O (0.56 ml,
0.72 mmol) was added to a suspension of copper iodide
(0.069 g, 0.36 mmol) in THF (2.00 mL) at 0 °C. The mixture
was stirred at this temperature for 20 minutes after which
chlorotrimethylsilane (0.14 ml, 0.54 mmol) then DHP 5
(0.10 mmol) in THF (2.00 mL) were added at −78 °C. The reac-
tion mixture was stirred at this temperature for 4.5 hours then
sat. aq. NH4Cl (1.70 mL) was added to the mixture, which was
stirred rapidly for 30 minutes at rt. The mixture was diluted
with H2O (10.0 mL) extracted with Et2O (2 × 20.0 mL) and
washed with H2O (20.0 mL) and brine (20.0 mL). The organic
layer was dried over MgSO4 and concentrated in vacuo. Flash
column chromatography (hexane–ethyl acetate 7 : 1 to 3 : 1)
aﬀorded the products as an inseparable mixture of enol and
ketone tautomers 8/9 which were then subjected to acylation.
The THP mixture 8/9 (0.03 mmol), acetic anhydride (0.10 mL,
0.10 mmol) and DMAP (2 mg) were stirred in pyridine
(0.47 mL) at 40 °C for 40 minutes. The mixture was cooled to
rt, concentrated in vacuo and partitioned between Et2O
(30.0 mL) and H2O (10.0 mL). The organic layer was washed
with H2O (10.0 mL) and brine (10.0 mL), then dried over
MgSO4 and concentrated in vacuo. Flash column chromato-
graphy (hexane–ethyl acetate) gave products 10.
(2R*,6S*)-Methyl 4-acetoxy-6-(furan-2-yl)-2-methyl-5,6-dihydro-
2H-pyran-3-carboxylate 10g. Dihydropyran 5a (0.028 g,
0.126 mmol), yielded 0.015 g (42% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2955, 2924, 2854, 1766, 1720, 1435,
1364, 1253, 1176, 1144, 1052, 742, 598 cm−1; δH (400 MHz,
CDCl3) 7.41 (1H, s), 6.37–6.35 (2H, m), 5.04 (1H, dd, J = 9.2,
4.2 Hz), 4.85 (1H, q, J = 6.5 Hz), 3.74 (3H, s), 2.79 (1H, dd, J =
17.9, 9.2 Hz), 2.53 (1H, dd, J = 17.9, 4.2 Hz,), 2.22 (3H, s) and
1.48 (3H, d, J = 6.5 Hz) ppm; δC (100 MHz, CDCl3) 168.5,
164.0, 157.5, 152.6, 142.9, 121.6, 110.4, 108.0, 69.0, 63.4, 51.9,
32.6, 21.1 and 19.3 ppm; m/z (ESI+) 303 (M + Na)+ (Found
303.0827 (M + Na)+. C14H16NaO6 requires; 303.0845).
(2R*,6S*)-Methyl 4-acetoxy-2-methyl-6-phenyl-5,6-dihydro-
2H-pyran-3-carboxylate 10h. Dihydropyran 5b (0.254 g,
1.094 mmol), yielded 0.149 g (47% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2945, 2931, 1766, 1720, 1708, 1664,
1365, 1247, 1174, 1053, 758, 698 cm−1; δH (400 MHz, C6D6)
7.30–7.23 (2H, m), 7.17–7.16 (1H, m), 7.14–7.05 (2H, m), 5.13
(1H, q, J = 6.6 Hz), 4.83 (1H, dd, J = 9.7, 4.1 Hz), 3.26 (3H, s),
2.40 (1H, dd, J = 17.9, 9.7 Hz), 2.31 (1H, dd, J = 17.9, 4.1 Hz),
1.88 (3H, s) and 1.39 (3H, d, J = 6.6 Hz) ppm; NOE C2(Me) –
H6 2.3% and C2(Me) – H5α 1.86%; δC (100 MHz, C6D6) 193.5,
167.8, 163.9, 154.1, 141.0, 128.6, 126.7, 121.7, 69.5, 68.8, 51.1,
36.9, 20.5 and 19.5 ppm; m/z (ESI+) 313 (M + Na)+ (Found
313.1040 (M + Na)+. C16H18NaO5 requires; 313.1052).
(2R*,6R*)-Methyl 4-acetoxy-2-methyl-6-propyl-5,6-dihydro-
2H-pyran-3-carboxylate 10i. Dihydropyran 5c (0.030 g,
0.151 mmol), yielded 0.015 g (40% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2955, 2931, 2872, 1768, 1723, 1710,
1435, 1363, 1254, 1177, 1149, 1055, 875, 480 cm−1; δH
(400 MHz, C6D6) 5.02 (1H, q, J = 6.5 Hz), 3.73–3.67 (1H, m),
3.25 (3H, s), 2.09–2.02 (2H, m), 1.90 (3H, s), 1.50–1.39 (2H, m),
1.35 (3H, d, J = 6.5 Hz), 1.31–1.12 (2H, m) and 0.82 (3H, t, J =
7.2 Hz) ppm; δC (100 MHz, C6D6) 193.3, 168.0, 163.9, 154.4,
121.8, 68.9, 66.4, 51.0, 37.6, 35.4, 20.7, 18.8 and 14.0 ppm; m/z
(ESI+) 279 (M + Na)+ (Found 279.1202 (M + Na)+. C13H20NaO5
requires; 279.1208).
(2R*,6S*)-Methyl 4-acetoxy-6-isopropyl-2-methyl-5,6-dihydro-
2H-pyran-3-carboxylate 10j. Dihydropyran 5d (0.713 g,
3.330 mmol), yielded 0.660 g (67% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2959, 2927, 2875, 1768, 1723, 1710,
1435, 1367, 1249, 1177, 1142, 1058, 875, 783 cm−1; δH
(400 MHz, C6D6) 5.00 (1H, q, J = 6.5 Hz), 3.45–3.40 (1H, m),
3.24 (3H, s), 2.17 (1H, dd, J = 17.7, 10.1 Hz), 2.02 (1H, dd, J =
17.7, 3.4 Hz), 1.92 (3H, s), 1.60–1.53 (1H, m), 1.34 (3H, d, J =
6.5 Hz), 0.93 (3H, d, J = 6.5 Hz) and 0.73 (3H, d, J = 6.5 Hz)
ppm; δC (100 MHz, C6D6) 193.5, 168.3, 164.1, 155.0, 121.8,
71.4, 69.0, 50.8, 33.0, 20.6, 19.3, 18.4 and 18.0 ppm; m/z (ESI+)
279 (M + Na)+ (Found 279.1199 (M + Na)+. C13H20NaO5
requires; 279.1208).
(2R*,6S*)-Methyl 4-acetoxy-2-methyl-6-(((triisopropylsilyl)
oxy)methyl)-5,6-dihydro-2H-pyran-3-carboxylate 10k. Dihydro-
pyran 5e (0.057 g, 0.166 mmol), yielded 0.040 g (61% after
2 steps), light yellow oil. ν max/cm−1 (film) 2941, 2866, 1771,
1725, 1712, 1365, 1246, 1177, 1149, 1055, 880, 681 cm−1; δH
(400 MHz, C6D6) 5.04 (1H, q, J = 6.5 Hz), 4.03–3.97 (1H, m),
3.76 (1H, dd, J = 10.2, 5.1 Hz), 3.63 (1H, dd, J = 10.2, 5.2 Hz),
3.23 (3H, s), 2.44 (1H, dd, J = 17.8, 10.0 Hz), 2.25 (1H, dd, J =
17.8, 3.8 Hz), 1.87 (3H, s), 1.39 (3H, d, J = 6.5 Hz) and 1.09
(21H, m) ppm; δC (100 MHz, C6D6) 168.0, 163.8, 154.4, 121.8,
69.1, 68.1, 66.4, 51.1, 32.0, 20.6, 19.4, 18.3 and 12.2 ppm; m/z
(ESI+) 423 (M + Na)+ (Found 423.2160 (M + Na)+. C20H36NaO6Si
requires; 423.2179).
(2R*,6S*)-Methyl 4-acetoxy-2-methyl-6-((E)-prop-1-en-1-yl)-
5,6-dihydro-2H-pyran-3-carboxylate 10l. Dihydropyran 5f
(0.050 g, 0.255 mmol), yielded 0.019 g (29% after 2 steps), light
yellow oil. ν max/cm−1 (film) 2952, 2930, 1767, 1721, 1664,
1436, 1366, 1245, 1212, 1176, 1046, 1050, 985 cm−1; δH
(400 MHz, CDCl3) 5.78 (1H, dd, J = 16.0, 4.0 Hz), 5.52 (1H, dq,
J = 16.0, 4.0 Hz), 4.85 (1H, q, J = 8.0 Hz), 4.37 (1H, ddd, J = 8.0,
4.0, 4.0 Hz), 3.72 (3H, s), 2.30 (2H, m), 2.20 (3H, s), 1.71 (2H,
d, J = 4.0 Hz) and 1.42 (3H, d, J = 8.0 Hz) ppm; δC (100 MHz,
CDCl3) 168.7, 164.1, 153.3, 130.2, 129.2, 121.3, 68.8, 67.9, 51.9,
34.8, 21.0, 19.6 and 17.9 ppm; m/z (ESI+) 277 (M + Na)+ (Found
277.1047 (M + Na)+. C13H18NaO5 requires; 277.1046).
Addition of n-Bu2CuLi. n-Butyl lithium 2.5 M in hexane solu-
tion (0.26 mL, 0.6 mmol) was added to a suspension of copper
iodide (57.2 mg, 0.3 mmol) in THF (1.70 mL) at 0 °C. The
Paper Organic & Biomolecular Chemistry
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mixture was stirred at this temperature for 20 minutes. After
this time the mixture was cooled to −78 °C and chlorotri-
methylsilane (0.12 mL, 0.9 mmol) was added, followed by
addition of DHP 5 (0.2 mmol) in THF (1.80 mL) at −78 °C. The
reaction mixture was stirred at −78 °C for 4 hours then
quenched with sat. aq. NH4Cl (1.50 mL) and allowed to warm
to rt with vigorous stirring. The mixture was diluted further
with sat. aq. NH4Cl (10.0 mL) and extracted with EtOAc (5 ×
15.0 mL). The combined organic extracts were washed with
H2O (15.0 mL) and brine (15.0 mL), then dried over MgSO4
and concentrated in vacuo. Flash column chromatography
(hexane–ethyl acetate) aﬀorded the products as an inseparable
mixture of enol and ketone tautomers 8/9, which were then
subjected to acylation. The THP mixture 8/9 (0.03 mmol),
acetic anhydride (0.10 mL, 0.10 mmol) and DMAP (2 mg) were
stirred in pyridine (0.47 mL) at 40 °C for 40 minutes. The
mixture was cooled to rt, concentrated in vacuo and partitioned
between Et2O (30.0 mL) and H2O (10.0 mL). The organic layer
was washed with H2O (10.0 mL) and brine (10.0 mL), then
dried over MgSO4 and concentrated in vacuo. Flash column
chromatography (hexane–ethyl acetate) gave products 10.
(2R*,6S*)-Methyl 4-acetoxy-2-butyl-6-phenyl-5,6-dihydro-
2H-pyran-3-carboxylate 10m. Dihydropyran 5g (0.100 g,
0.431 mmol), yielded 0.056 g (39% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2953, 2860, 1764, 1721, 1248, 1174,
1055, 698 cm−1; δH (400 MHz, CDCl3) 7.40–7.29 (5H, m), 4.92
(1H, dd, J = 9.0, 5.0 Hz), 4.79 (1H, d, J = 10.1 Hz), 3.75 (3H, s),
2.69–2.47 (2H, m), 2.21 (3H, s), 1.88–1.24 (6H, m), 0.89 (3H, t,
J = 7.3 Hz) ppm; δC (100 MHz, CDCl3) 168.9, 164.1, 153.2,
141.0, 128.6, 128.0, 126.0, 121.2, 73.2, 68.4, 51.8, 36.0, 32.2,
28.3, 22.4, 21.0 and 14.0 ppm; m/z (ESI+) 355 (M + Na)+ (Found
355.1509 (M + Na)+. C19H24NaO5 requires; 355.1516).
(2R*,6R*)-Methyl 4-acetoxy-2-butyl-6-propyl-5,6-dihydro-
2H-pyran-3-carboxylate 10n. Dihydropyran 5c (0.070 g,
0.353 mmol), yielded 0.037 g (35% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2956, 2932, 2872, 1767, 1722, 1241,
1177, 1053, 900 cm−1; δH (400 MHz, CDCl3) 4.61 (1H, d, J =
10.3 Hz), 2.84 (1H, m), 3.71 (3H, s), 2.22–2.16 (2H, m),
2.18 (3H, s), 1.74–1.25 (10H, m), 0.95–0.88 (6H, m) ppm;
δC (100 MHz, CDCl3) 168.6, 164.3, 153.9, 121.1, 77.3, 72.5,
66.2, 51.8, 37.7, 35.0, 32.0, 28.2, 22.3, 21.0, 18.8 and 14.1 ppm;
m/z (ESI+) 321 (M + Na)+ (Found 321.1681 (M + Na)+.
C16H26NaO5 requires; 321.1672).
(2R*,6S*)-Methyl 4-acetoxy-2-butyl-6-isopropyl-5,6-dihydro-
2H-pyran-3-carboxylate 10o. Dihydropyran 5d (0.037 g,
0.186 mmol) yielded 0.020 g (37% after 2 steps), light yellow
oil. ν max/cm−1 (film) 2955, 2929, 1767, 1724, 1712, 1435,
1365, 1249, 1202, 1177, 1056, 490 cm−1; δH (400 MHz, C6D6)
4.89 (1H, d, J = 10.0 Hz), 3.43–3.38 (1H, m), 3.28 (3H, s), 2.15
(1H, dd, J = 17.7, 9.6 Hz), 2.07 (1H, dd, J = 17.7, 4.3 Hz), 1.92
(3H, s), 1.74–1.53 (2H, m), 1.48–1.39 (1H, m), 1.37–1.24 (4H,
m), 0.96 (3H, d, J = 6.7 Hz), 0.88 (3H, t, J = 7.3 Hz) and 0.74
(3H, d, J = 6.8 Hz) ppm; δC (100 MHz, C6D6) 167.9, 164.0,
154.4, 121.4, 72.8, 71.4, 51.0, 33.0, 32.9, 32.2, 28.7, 22.6, 20.6,
18.6, 18.3 and 14.2 ppm; m/z (ESI+) 321 (M + Na)+ (Found
321.1669 (M + Na)+. C16H26NaO5 requires; 321.1672).
(2R*,6S*)-Methyl 4-acetoxy-2-butyl-6-(((triisopropylsilyl)oxy)-
methyl)-5,6-dihydro-2H-pyran-3-carboxylate 10p. Dihydropyran
5e (0.056 g, 0.163 mmol), yielded 0.012 g (16% after 2 steps),
light yellow oil. ν max/cm−1 (film) 2941, 2865, 1770, 1725,
1712, 1364, 1247, 1192, 1177, 1146, 1094, 1052, 881, 786, 681,
659 cm−1; δH (400 MHz, C6D6) 4.89 (1H, d, J = 9.6 Hz),
3.99–3.93 (1H, m), 3.75 (1H, dd, J = 10.3, 5.6 Hz), 3.61 (1H, dd,
J = 10.3, 4.8 Hz), 3.27 (3H, s), 2.35 (1H, dd, J = 17.9, 10.0 Hz),
2.21 (1H, dd, J = 17.9, 3.9 Hz), 1.87 (3H, s), 1.73–1.59 (2H, m),
1.49–1.39 (2H, m), 1.38–1.23 (2H, m), 1.10 (21H, m) and 0.89
(3H, t, J = 7.3 Hz) ppm; δC (100 MHz, C6D6) 167.9, 163.9,
154.0, 121.5, 72.8, 67.9, 66.5, 51.0, 32.4, 31.8, 28.5, 22.6, 20.6,
18.2, 14.2 and 12.2 ppm; m/z (ESI+) 465 (M + Na)+ (Found
465.2625 (M + Na)+. C23H42NaO6Si requires; 465.2643).
General procedure for the synthesis of 3,6-disubstituted-
tetrahydropyran-4-ones 11
A 1.0 M solution of L-Selectride in THF (0.04 mL, 0.04 mmol)
was added to a stirred solution of DHP (0.04 mmol) in THF
(1.00 mL) at −78 °C. The mixture was stirred for 1 hour at
−78 °C then diluted with Et2O (10.0 mL) and quenched with
sat. aq. NHCl4 (10.0 mL). The layers were separated and the
aqueous layer was extracted with Et2O (10.0 mL). The com-
bined organic extracts were washed with brine (20.0 mL), dried
over MgSO4 and concentrated in vacuo. Purification by flash
column chromatography (hexane–ethyl acetate) aﬀorded the
product as a mixture of enol/keto tautomers.
Methyl 6-(furan-2-yl)-4-hydroxy-5,6-dihydro-2H-pyran-3-carb-
oxylate 11a. Dihydropyran 5a (0.098 g, 0.439 mmol), yielded
0.043 g (44%) oil. ν max/cm−1 (film) 2954, 2927, 2868, 1737,
1667, 1627, 1442, 1275, 1066, 1011, 739, 598 cm−1; 1H NMR
(400 MHz, CDCl3): δ 11.81 (OH, s), 7.42 (1H, m), 7.38 (1H, m,
keto) 6.37–6.33 (2H, m), 6.28–6.27 (2H, m, keto), 5.08 (1H, dd,
J = 11.6, 2.9 Hz, keto), 4.88 (1H, dd, J = 10.0, 3.6 Hz, keto), 4.73
(1H, dd, J = 9.9, 3.9 Hz), 4.50 (2H, m), 4.44 (1H, d, J = 14.0),
4.37 (1H, d, J = 14.0 Hz), 3.77 (3H, s), 3.70 (3H, s, keto), 2.86
(1H, dd, J = 17.8, 9.9 Hz), 2.80 (1H, m, keto), 2.53 (1H, dd, J =
17.8, 3.8 Hz), 2.08 (1H, m, keto) ppm; δC (100 MHz, CDCl3):
170.4, 168.2, 152.7, 143.0, 110.4, 107.9, 106.2 (keto), 97.1, 72.9
(keto), 68.9, 67.7 (keto), 62.9, 51.6, 31.9 and 26.1 (keto) ppm;
m/z (ESI+) 247 (M + Na)+. (Found 247.0575 (M + Na)+.
C11H12NaO5 requires 247.0577).
Methyl 4-hydroxy-6-phenyl-5,6-dihydro-2H-pyran-3-carb-
oxylate 11b. Dihydropyran 5b (0.100 g, 0.427 mmol), yielded
0.074 g (74%). oil. ν max/cm−1 (film) 2952, 2922, 2852, 1664,
1622, 1445, 1269, 1209, 1066, 1027, 699 cm−1; 1H NMR
(400 MHz, CDCl3): δ 11.29 (OH, s), 7.43–7.29 (5H, m), 4.70 (1H,
m, keto) 4.67 (1H, dd, J = 10.48, 3.71 Hz), 4.59 (1H, m, keto),
4.55–4.36 (2H, m, keto), 4.44 (1H, d, J = 14.0), 4.39 (1H, d, J =
14.0 Hz), 3.81 (3H, s), 3.80 (3H, s, keto), 3.02–2.68 (2H, m, keto)
and 2.67–2.49 (2H, m) ppm; δC (100 MHz, CDCl3): 170.5,
168.8, 168.0 (keto), 140.8, 140.0 (keto), 128.9 (keto), 128.7, 128.5
(keto), 128.1, 125.9, 125.7 (keto), 97.2, 80.4 (keto), 75.6, 68.3
(keto), 63.5, 57.3 (keto), 53.0 (keto), 51.6, 49.5 (keto), 48.7 (keto)
and 35.8 ppm; m/z (ESI+) 257 (M + Na)+. (Found 257.0782
(M + Na)+. C13H14NaO4 requires 257.0784).
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Methyl 4-hydroxy-6-propyl-5,6-dihydro-2H-pyran-3-carb-
oxylate 11c. Dihydropyran 5c (0.100 g, 0.505 mmol), yielded
0.089 g, (89%). oil. ν max/cm−1 (film) 2957, 2871, 1666, 1626,
1441, 1213, 1074, 807 cm−1; 1H NMR (400 MHz, C6D6): δ 12.09
(OH, s), 4.50 (1H, d, J = 13.7), 4.40 (1H, m, keto), 4.11 (1H, d,
J = 13.7 Hz), 4.05 (1H, m, keto), 3.22 (3H, s), 3.21 (3H, s, keto),
3.20 (1H, m), 3.05 (1H, m, keto), 2.12 (2H, m, keto), 2.08 (1H,
m), 1.94 (1H, m), 1.47–0.96 (4H, m) and 0.79 (3H, t, J = 7.2 Hz)
ppm; δC (100 MHz, C6D6): 200.8 (keto), 170.8, 170.0, 168.0
(keto), 97.5, 78.2 (keto), 73.5, 68.1 (keto), 63.2, 57.5 (keto), 51.6
(keto), 50.9, 47.7 (keto), 38.3 (keto), 37.9, 34.6, 18.7, 18.5 (keto),
14.1 and 14.0 (keto) ppm; m/z (ESI+) 223 (M + Na)+. (Found
223.0938 (M + Na)+. C10H16NaO4 requires 223.0941).
Methyl 4-hydroxy-6-(((triisopropylsilyl)oxy)methyl)-5,6-
dihydro-2H-pyran-3-carboxylate 11e. Dihydropyran 5e (0.095 g,
0.277 mmol), yielded 0.062 g, (65%) oil. ν max/cm−1 (film)
2924, 2865, 1774, 1729, 1709, 1148, 1057, 881, 787, 681 cm−1;
1H NMR (400 MHz, CDCl3): δ 11.78 (OH, s), 4.69–4.66 (2H, m,
keto), 4.43 (1H, d, J = 13.9), 4.22 (1H, d, J = 13.9 Hz), 3.93 (1H,
m, keto), 3.88 (1H, m), 3.83–3.79 (2H, m), 3.76 (3H, s, keto),
3.75 (3H, s), 3.62–3.59 (2H, m, keto), 2.82 (1H, m, keto),
2.61–2.28 (2H, m), 2.31 (1H, m, keto) and 1.06–1.05 (21H, m)
ppm; δC (100 MHz, CDCl3): 170.5, 169.5, 97.1, 79.2 (keto), 74.6,
68.2 (keto), 66.0, 63.2, 57.3 (keto), 52.4 (keto), 51.5, 44.2 (keto),
31.3, 18.8, 12.0 ppm; m/z (ESI+) 367 (M + Na)+. (Found
367.1905 (M + Na)+. C17H32NaO5Si requires 367.1911).
(E)-Methyl 4-hydroxy-6-styryl-5,6-dihydro-2H-pyran-3-carb-
oxylate 11g. Dihydropyran 5g (0.100 g, 0.387 mmol), yielded
0.051 g, (51%) oil. ν max/cm−1 (film) 2953, 2839, 1665, 1626,
1441, 1263, 1211, 1059, 965, 795, 746, 692 cm−1; 1H NMR
(400 MHz, CDCl3): δ 11.78 (OH, s), 7.41–7.23 (5H, m), 6.65 (1H,
d, J = 16.0 Hz), 6.58 (1H, m, keto), 6.23 (1H, dd, J = 16.0,
6.0 Hz), 6.19 (1H, m, keto), 4.48 (1H, d, J = 13.9), 4.47 (1H, m,
keto), 4.32 (1H, d, J = 13.9 Hz), 4.28 (1H, m), 4.26 (1H, m, keto),
3.79 (3H, s, keto), 3.77 (3H, s), 2.84 (1H, m, keto), 2.67 (1H, m,
keto) and 2.69–2.38 (2H, m) ppm; δC (100 MHz, CDCl3): 170.5,
168.5, 136.4, 136.0 (keto), 132.3 (keto), 131.8, 128.7, 128.2,
128.1, 126.8 (keto), 126.7, 97.2, 74.0, 68.0 (keto), 62.9, 52.4
(keto), 51.6, 47.7 (keto) and 34.3 ppm; m/z (ESI+) 283 (M + Na)+.
(Found 283.0934 (M + Na)+. C15H16NaO4 requires 283.0941).
General procedure for the acylation of 3,6-disubstituted-
tetrahydropyran-4-ones 11, formation of enol acetates 12
The THP keto/enol 11 mixture (0.03 mmol), acetic anhydride
(0.10 mL, 0.1 mmol) and DMAP (2 mg.) were stirred in pyridine
(0.47 mL) at 40 °C for 40 minutes. The mixture was cooled to
room temperature, concentrated in vacuo and partitioned
between Et2O (30.0 mL) and H2O (10.0 mL). The organic layer
was washed with H2O (10.0 mL) and brine (10.0 mL), then dried
over MgSO4 and concentrated in vacuo. Flash column chromato-
graphy (hexane–ethyl acetate) gave the product.
Methyl 4-acetoxy-6-(furan-2-yl)-5,6-dihydro-2H-pyran-3-carb-
oxylate 12a. Tetrahydropyran-4-one 11a (0.043 g, 0.191 mmol),
yielded 0.029 g, (58%) oil. ν max/cm−1 (film) 2953, 2847, 1760,
1723, 1706, 1671, 1365, 1253, 1173, 1132, 1059, 1009,
743 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.41 (1H, s), 6.41 (1H,
m), 6.35 (1H, m), 4.80 (1H, dd, J = 9.0, 4.1 Hz), 4.51–4.48 (2H,
m), 3.72 (3H, s) 2.89 (1H, m), 2.55 (1H, m) and 2.52 (3H, s)
ppm; δC (100 MHz, CDCl3): 168.4, 163.1, 153.5, 152.2, 143.0,
116.5, 110.4, 108.3, 68.7, 64.0, 51.8, 32.4 and 21.0 ppm; m/z
(ESI+) 289 (M + Na)+. (Found 289.0692 (M + Na)+. C13H14NaO6
requires 289.0683).
Methyl 4-acetoxy-6-phenyl-5,6-dihydro-2H-pyran-3-carb-
oxylate 12b. Tetrahydropyran-4-one 11b (0.074 g, 0.316 mmol),
yielded 0.059 g (68%) solid white. ν max/cm−1 (film) 2949,
2842, 1765, 1718, 1664, 1166, 1131, 1060, 743, 700 cm−1;
1H NMR (400 MHz, CDCl3): δ 7.38–7.28 (5H, m), 6.69 (1H, d,
J = 16.0 Hz), 4.67 (1H, m), 4.49 (1H, d, J = 16.0, 4.0 Hz), 3.74
(3H, s), 2.63 (1H, m), 2.47 (1H, m) and 2.24 (3H, s) ppm;
δC (100 MHz, CDCl3): 168.4, 163.3, 154.1, 140.4, 128.7, 128.2,
125.9, 116.5, 75.5, 64.9, 51.7, 36.5 and 21.0 ppm; m/z (ESI+) 299
(M + Na)+. (Found 299.0894 (M + Na)+. C15H16NaO5 requires
299.0890).
Methyl 4-acetoxy-6-propyl-5,6-dihydro-2H-pyran-3-carb-
oxylate 12c. Tetrahydropyran-4-one 11c (0.090 g, 0.450 mmol),
yielded 0.056 g (51%) oil. ν max/cm−1 (film) 2957, 2872, 1768,
1726, 1250, 1212, 1177, 1055 cm−1; 1H NMR (400 MHz, CDCl3):
4.53 (1H, dd, J = 15.0 Hz), 4.31 (1H, dd, J = 15.0 Hz), 3.70 (3H,
s), 3.60 (1H, m), 2.30–2.14 (2H, m), 2.23 (3H, s) 1.64–1.50 (5H,
m) and 0.93 (3H, t, J = 7.2 Hz) ppm; δC (100 MHz, CDCl3):
168.4, 163.5, 154.5, 116.3, 73.5, 64.6, 51.7, 37.4, 35.0, 21.0, 18.5
and 14.1 ppm; m/z (ESI+) 265 (M + Na)+. (Found 265.1052
(M + Na)+. C12H18NaO5 requires 265.1046).
Methyl 4-acetoxy-6-(((triisopropylsilyl)oxy)methyl)-5,6-
dihydro-2H-pyran-3-carboxylate 12e. Tetrahydropyran-4-one
11e (0.040 g, 0.116 mmol), yielded 0.029 g (65%) oil.
ν max/cm−1 (film) 2924, 2865, 1774, 1729, 1709, 1148, 1057,
881, 787, 681 cm−1; 1H NMR (400 MHz, C6D6): 4.70 (1H, dd, J =
15.5, 2.0 Hz), 4.33 (1H, dd, J = 15.5, 3.4 Hz), 3.82 (1H, dd, J =
10.0, 5.0 Hz), 3.70 (1H, dd, J = 10.0, 5.0 Hz), 3.65 (1H, m), 3.30
(3H, s), 2.59 (1H, m), 2.27 (1H, m), 2.02 (3H, s) and 1.18–1.17
(21H, m) ppm; δC (100 MHz, C6D6): 167.7, 163.0, 154.9, 116.7,
74.7, 66.1, 64.8, 50.8, 32.0, 20.6, 18.1 and 12.2 ppm; m/z (ESI+)
409 (M + Na)+. (Found 409.2022 (M + Na)+. C19H34NaO6Si
requires 409.2017).
(E)-Methyl 4-acetoxy-6-styryl-5,6-dihydro-2H-pyran-3-carb-
oxylate 12g. Tetrahydropyran-4-one 11g (0.015 g, 0.057 mmol),
yielded 0.010 g (56%) oil. ν max/cm−1 (film) 3026, 2951, 2844,
1761, 1723, 1705, 1248, 1172, 1142, 1051, 748, 693 cm−1;
1H NMR (400 MHz, CDCl3): δ 7.40–7.23 (5H, m), 6.68 (1H, d,
J = 16.0 Hz), 6.23 (1H, dd, J = 16.0, 6.1 4.1 Hz), 4.63 (1H, d, J =
15.0 Hz), 4.43 (1H, d, J = 15.0 Hz), 4.33 (1H, m), 3.72 (3H, s)
2.52 (1H, m), 2.37 (1H, m) and 2.24 (3H, s) ppm; δC (100 MHz,
CDCl3): 168.4, 163.3, 153.8, 136.3, 132.1, 128.7, 128.1, 127.6,
126.7, 116.5, 73.9, 64.3, 51.8, 34.9 and 21.0 ppm; m/z (ESI+) 325
(M + Na)+. (Found 325.1053 (M + Na)+. C17H18NaO5 requires
325.1046).
General procedure for the synthesis of 3,3,6-trisubstituted
tetrahydropyran-4-ones 13
A 1.0 M solution of L-Selectride in THF (0.04 mL, 0.04 mmol)
was added to a stirred solution of DHP (0.04 mmol) in THF
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(1.00 mL) at −78 °C. The mixture was stirred for 1 hour at this
temperature before addition of the electrophile (0.4 mmol). The
reaction mixture was stirred at room temperature until com-
pletion then diluted with Et2O (10.0 mL) and quenched with
sat. aq. NHCl4 (10.0 mL). The layers were separated and
aqueous layer was extracted with Et2O (10.0 mL). The combined
organic extracts were washed with brine (20.0 mL), dried over
MgSO4 and concentrated in vacuo. Purification by flash column
chromatography (hexane–ethyl acetate) to aﬀorded the product.
(3S*,6S*)-Methyl 3-methyl-4-oxo-6-phenyltetrahydro-2H-
pyran-3-carboxylate 13a. Dihydropyran 5b (0.100 g,
0.431 mmol), yielded 0.063 g (59%) oil. ν max/cm−1 (film)
3032, 2953, 2877, 1736, 1710, 1268, 1233, 1095, 1075, 699,
762 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.41–7.31 (5H, m),
4.89 (1H, dd, J = 9.5, 4.1 Hz), 4.29 (1H, d, J = 11.7 Hz), 3.94
(1H, d, J = 11.7 Hz), 3.79 (3H, s), 2.86 (1H, dd, J = 15.2, 9.5 Hz),
2.75 (1H, dd, J = 15.2, 4.1 Hz) and 1.54 (3H, s) ppm; δC
(100 MHz, CDCl3): 204.9, 171.3, 139.8, 128.8, 128.4, 126.0,
79.5, 72.5, 58.6, 52.6, 45.1 and 18.6 ppm; m/z (ESI+) 271
(M + Na)+. (Found 271.0936 (M + Na)+. C14H16NaO4 requires
271.0941).
(3S*,6S*)-Methyl 3-methyl-4-oxo-6-((E)-styryl)tetrahydro-2H-
pyran-3-carboxylate 13b. Dihydropyran 5g (0.120 g,
0.465 mmol), yielded 0.068 g (53%) oil. ν max/cm−1 (film)
3026, 2952, 2875, 1733, 1713, 1232, 1264, 1114, 1088, 967, 748,
693 cm−1; 1H NMR (400 MHz, C6D6): δ 7.18–7.02 (5H, m), 6.44
(1H, d, J = 16.0 Hz), 5.94 (1H, dd, J = 16.0, 5.3 Hz), 4.19 (1H, d,
J = 11.6 Hz), 4.06 (1H, ddd, J = 9.0, 5.3, 4.4 Hz), 3.66 (1H, d, J =
11.6 Hz), 3.36 (3H, s), 2.41 (1H, dd, J = 15.0, 4.4 Hz), 2.29 (1H,
dd, J = 15.0, 9.0 Hz) and 1.31 (3H, s) ppm; δC (100 MHz, C6D6):
203.2, 171.9, 136.6, 132.2, 128.9, 128.1, 127.9, 126.9, 77.7, 72.1,
58.7, 52.0, 43.9 and 18.1 ppm; m/z (ESI+) 297 (M + Na)+. (Found
297.1095 (M + Na)+. C16H18NaO4 requires 297.1097).
(3S*,6S*)-Methyl 3-methyl-4-oxo-6-(((triisopropylsilyl)oxy)
methyl)tetrahydro-2H-pyran-3-carboxylate 13c. Dihydropyran
5d (0.097 g, 0.280 mmol), yielded 0.057 g (57%) oil.
ν max/cm−1 (film) 2942, 2866, 1738, 1715, 1105, 881, 681,
659 cm−1; 1H NMR (400 MHz, C6D6): 4.13 (1H, d, J = 11.4 Hz),
3.73 (1H, d, J = 11.4 Hz), 3.58 (1H, dddd, J = 10.0, 3.8, 3.8,
3.5 Hz), 3.45 (1H, dd, J = 8.0, 3.8 Hz), 3.40 (1H, dd, J = 8.0, 3.8
Hz), 3.36 (3H, s), 2.59 (1H, dd, J = 15.1, 10.0 Hz), 2.25 (1H, dd,
J = 15.1, 3.5 Hz), 1.43 (3H, s) and 1.05–104 (21H, m) ppm;
δC (100 MHz, C6D6): 205.0, 171.1, 78.6, 73.0, 65.9, 58.8, 51.9,
40.2, 18.6, 18.1 and 12.2 ppm; m/z (ESI+) 381 (M + Na)+. (Found
381.2065 (M + Na)+. C18H34NaO5Si requires 381.2068).
(3S*,6R*)-Methyl 3-methyl-4-oxo-6-propyltetrahydro-2H-
pyran-3-carboxylate 13d. Dihydropyran 5c (0.100 g,
0.505 mmol), yielded 0.063 g (58%) oil. ν max/cm−1 (film)
2956, 2929, 2872, 1738, 1714, 1263, 1100, 782 cm−1; 1H NMR
(400 MHz, C6D6): δ 4.08 (1H, d, J = 11.5 Hz), 3.62 (1H, d, J =
11.5 Hz), 3.38 (3H, s), 3.24 (1H, m), 2.12 (1H, dd, J = 15.0,
3.6 Hz), 1.99 (1H, dd, J = 15.0, 10.2 Hz), 1.35 (3H, s), 1.32–0.93
(4H, m) and 0.74 (3H, t, J = 7.3 Hz) ppm; δC (100 MHz, C6D6):
204.3, 171.9, 77.8, 72.2, 58.8, 51.8, 44.2, 37.7, 18.7, 18.5 and
14.0 ppm; m/z (ESI+) 237 (M + Na)+. (Found 237.1100
(M + Na)+. C11H18NaO4 requires 237.1097).
(3S*,6S*)-Methyl 3-allyl-4-oxo-6-phenyltetrahydro-2H-pyran-
3-carboxylate 13e. Dihydropyran 5b (0.100 g, 0.431 mmol),
yielded 0.061 g (52%) oil. ν max/cm−1 (film) 3065, 2952, 2875,
1736, 1711, 1227, 1076, 763, 699 cm−1; 1H NMR (400 MHz,
CDCl3): δ 7.42–7.32 (5H, m), 5.80 (1H, m), 5.20 (1H, dd, J =
17.2, 4.4 Hz), 5.15 (1H, dd, J = 10.1, 4.4 Hz), 4.86 (1H, dd, J =
9.3, 4.6 Hz), 4.21 (1H, d, J = 11.8 Hz), 4.12 (1H, d, J = 11.8 Hz),
3.79 (3H, s) and 2.82–2.71 (4H, m) ppm; δC (100 MHz, CDCl3):
203.8, 170.2, 139.9, 132.1, 128.8, 128.4, 126.0, 119.9, 79.6, 70.1,
62.5, 52.5, 46.2 and 36.1 ppm; m/z (ESI+) 297 (M + Na)+. (Found
297.1101 (M + Na)+. C16H18NaO4 requires 297.1097).
(3S*,6S*)-Methyl 3-allyl-4-oxo-6-((E)-styryl)tetrahydro-2H-
pyran-3-carboxylate 13f. Dihydropyran 5f (0.100 g,
0.387 mmol), yielded 0.097 g (83%) oil. ν max/cm−1 (film)
2952, 1736, 1712, 1226, 1073, 1031, 966, 748, 693 cm−1;
1H NMR (400 MHz, C6D6): δ 7.19–7.02 (5H, m), 6.45 (1H, dd,
J = 16.0, 1.2 Hz), 5.95 (1H, dd, J = 16.0, 5.4 Hz), 5.88 (1H, dddd,
J = 17.1, 10.1, 7.5, 7.0 Hz), 5.05 (1H, dd, J = 17.1, 4.4 Hz), 4.99
(1H, dd, J = 10.1, 4.4 Hz), 4.16 (1H, d, J = 11.8 Hz), 4.03 (1H,
dddd, J = 9.0, 5.4, 4.2, 1.2 Hz), 3.98 (1H, d, J = 11.8 Hz), 3.36
(3H, s), 2.69 (1H, dd, J = 13.8, 7.0 Hz), 2.52 (1H, dd, J = 13.8,
7.5 Hz), 2.41 (1H, dd, J = 14.7, 4.2 Hz) and 2.31 (1H, dd, J =
14.7, 9.0 Hz) ppm; δC (100 MHz, C6D6): 202.6, 170.2, 136.6,
133.0, 132.1, 128.9, 126.9, 119.4, 77.8, 69.8, 62.7, 51.9, 44.8
and 35.9 ppm; m/z (ESI+) 323 (M + Na)+. (Found 323.1242
(M + Na)+. C16H21NaO4 requires 323.1230).
(3S*,6S*)-Methyl 3-allyl-4-oxo-6-(((triisopropylsilyl)oxy)-
methyl)tetrahydro-2H-pyran-3-carboxylate 13g. Dihydropyran
5e (0.096 g, 0.280 mmol), yielded 0.061 g (57%) oil.
ν max/cm−1 (film) 2943, 2866, 1739, 1715, 1231, 1124, 1083, 881,
680, 660 cm−1; 1H NMR (400 MHz, C6D6): δ 6.05 (1H, dddd, J =
16.8, 9.9, 7.1, 7.0 Hz), 5.29 (1H, dd, J = 16.8, 1.8 Hz), 5.14 (1H,
dd, J = 9.9, 1.8 Hz), 4.17 (1H, d, J = 11.6 Hz), 4.14 (1H, d, J =
11.6 Hz), 3.70 (1H, m), 3.50 (2H, m), 3.47 (3H, s), 2.90 (1H, dd,
J = 13.6, 7.0 Hz), 2.79 (1H, dd, J = 13.6, 7.1 Hz), 2.73 (1H, dd,
J = 15.0, 8.0 Hz) and 2.33 (1H, dd, J = 15.0, 3.2 Hz)
and 1.16–1.14 (21H, m) ppm; δC (100 MHz, C6D6): 203.6,
170.1, 133.2, 119.4, 78.7, 70.3, 65.8, 62.7, 51.8, 41.0, 36.0,
18.1 and 12.2 ppm; m/z (ESI+) 407 (M + Na)+. (Found 407.2211
(M + Na)+. C20H36NaO5Si requires 407.2224).
(3S*,6R*)-Methyl 3-allyl-4-oxo-6-propyltetrahydro-2H-pyran-3-
carboxylate 13h. Dihydropyran 5c (0.100 g, 0.505 mmol),
yielded 0.063 g (52%) oil. ν max/cm−1 (film) 2958, 2873, 1737,
1712, 1229, 1081, 922 cm−1; 1H NMR (400 MHz, CDCl3): δ 5.76
(1H, dddd, J = 17.4, 10.2, 7.3, 7.2 Hz), 5.18 (1H, dd, J = 17.4,
1.4 Hz), 5.10 (1H, dd, J = 10.2, 1.4 Hz), 4.05 (1H, d, J = 11.8 Hz),
4.01 (1H, d, J = 11.8 Hz), 3.74 (3H, s), 3.74 (1H, m), 2.69 (1H,
dd, J = 13.8, 7.3 Hz), 2.64 (1H, dd, J = 13.8, 7.2 Hz), 2.45 (1H,
dd, J = 14.8, 3.6 Hz), 2.36 (1H, J = 14.8, 10.0 Hz), 1.51–1.34 (4H,
m, H-7) and 0.93 (1H, t, J = 7.0 Hz) ppm; δC (100 MHz, CDCl3):
204.6, 170.3, 132.3, 119.7, 78.1, 70.1, 62.5, 52.4, 45.2, 37.7,
36.0, 18.4 and 13.9 ppm; m/z (ESI+) 263 (M + Na)+. (Found
263.1264 (M + Na)+. C13H20NaO4 requires 263.1254).
(3S*,6S*)-Methyl 3-benzyl-4-oxo-6-phenyltetrahydro-2H-
pyran-3-carboxylate 13i. Dihydropyran 5b (0.050 g,
0.215 mmol), yielded 0.045 g (65%) oil. ν max/cm−1 (film)
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2948, 2920, 1710, 1207, 1073, 767, 702, 597 cm−1; 1H NMR
(400 MHz, CDCl3): δ 7.41–7.24 (10H, m), 4.89 (1H, dd, J = 10.0,
3.9 Hz), 4.13 (1H, d, J = 12.4 Hz), 4.10 (1H, d, J = 12.4 Hz), 3.76
(3H, s), 3.40 (1H, d, J = 13.4 Hz), 3.33 (1H, d, J = 13.4 Hz), 2.96
(1H, dd, J = 15.1, 10.0 Hz) and 2.78 (1H, dd, J = 15.1, 3.9 Hz)
ppm; NOE H6 – H5α 3.6%, H5α – H6 2.26%, H5β – benzyl–
CH2 3.16%; δC (100 MHz, CDCl3): 203.9, 169.7, 140.1, 135.0,
130.8, 128.9, 128.6, 128.5, 127.3, 126.0, 80.0, 69.1, 63.9, 52.4,
46.0 and 37.0 ppm; m/z (ESI+) 347 (M + Na)+. (Found 347.1252
(M + Na)+. C20H20NaO4 requires 347.1254).
(3S*,6S*)-Methyl 3-benzyl-4-oxo-6-((E)-styryl)tetrahydro-2H-
pyran-3-carboxylate 13j. Dihydropyran 5g (0.096 g,
0.372 mmol), yielded 0.066 g (51%) oil. ν max/cm−1 (film)
2958, 2860, 1734, 1712, 1209, 1070, 742, 703, 597 cm−1;
1H NMR (400 MHz, CDCl3): δ 7.42–7.19 (10H, m), 6.67 (1H, dd,
J = 16.1, 1.0 Hz), 6.26 (1H, dd, J = 16.1, 5.7 Hz), 4.59 (1H, dddd,
J = 8.6, 5.7, 4.5, 1.0 Hz), 4.11 (1H, d, J = 12.2 Hz), 4.05 (1H, d,
J = 12.2 Hz), 3.73 (3H, s), 3.34 (1H, d, J = 13.5 Hz), 3.20 (1H, d,
J = 13.5 Hz), 2.83 (1H, dd, J = 14.8, 8.6 Hz) and 2.73 (1H, dd, J =
14.8, 4.5 Hz) ppm; δC (100 MHz, CDCl3): 204.0, 169.8, 136.0,
135.1, 132.9, 130.7, 128.8, 128.5, 128.4, 127.4, 127.3, 126.8,
78.1, 68.7, 63.8, 52.5, 44.6 and 36.7 ppm; m/z (ESI+) 373
(M + Na)+. (Found 373.1401 (M + Na)+. C22H22NaO4 requires
373.1410).
(3S*,6S*)-Methyl 3-benzyl-4-oxo-6-(((triisopropylsilyl)oxy)-
methyl)tetrahydro-2H-pyran-3-carboxylate 13k. Dihydropyran
5e (0.100 g, 0.292 mmol), yielded 0.078 g (62%) oil.
ν max/cm−1 (film) 2942, 2865, 1736, 1713, 1121, 1074, 881, 682,
660 cm−1; 1H NMR (400 MHz, C6D6): δ 7.48–7.02 (5H, m), 4.15
(1H, d, J = 12.0 Hz), 3.97 (1H, d, J = 12.0 Hz), 3.64 (1H, m), 3.43
(2H, m), 3.34 (3H, s), 3.42 (1H, d, J = 13.0 Hz), 3.27 (1H, d, J =
13.0 Hz), 2.79 (1H, dd, J = 15.0, 10.6 Hz), 2.22 (1H, dd, J = 15.0,
3.4 Hz) and 1.08–1.00 (21H, m) ppm; δC (100 MHz, C6D6):
203.7, 169.6, 135.9, 131.2, 128.6, 128.1, 127.9, 127.3, 79.0, 69.2,
65.8, 64.2, 51.7, 40.5, 36.6, 18.1 and 12.2 ppm; m/z (ESI+) 457
(M + Na)+. (Found 457.2388 (M + Na)+. C24H38NaO5Si requires
457.2381).
(3S*,6R*)-Methyl 3-benzyl-4-oxo-6-propyltetrahydro-2H-
pyran-3-carboxylate 13l. Dihydropyran 5c (0.050 g,
0.252 mmol), yielded 0.045 g (62%) oil. ν max/cm−1 (film)
2956, 2932, 2872, 1734, 1711, 1262, 1206, 1077, 1016,
702 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.27–7.20 (5H, m),
3.99 (1H, d, J = 12.2 Hz), 3.94 (1H, d, J = 12.2 Hz), 3.81 (1H, m),
3.70 (3H, s), 3.31 (1H, d, J = 13.4 Hz), 3.21 (1H, d, J = 13.4 Hz),
2.56 (1H, dd, J = 15.0, 9.8 Hz), 2.48 (1H, dd, J = 15.0, 3.8 Hz),
1.58–1.37 (4H, m) and 0.95 (3H, t, J = 7.16 Hz) ppm;
δC (100 MHz, CDCl3): 204.7, 169.8, 135.2, 130.7, 128.5, 127.7,
78.4, 69.0, 63.9, 52.3, 44.9, 37.7, 36.8, 18.3 and 14.0 ppm; m/z
(ESI+) 313 (M + Na)+. (Found 313.1416 (M + Na)+. C17H22NaO4
requires 313.1410).
Synthesis of diospongin B 2
(E)-Methyl 5-hydroxy-3-oxo-7-phenylhept-6-enoate 7g. Tita-
nium tetraisopropoxide (11.48 mL, 38.80 mmol) was added to
a stirred solution of cinnamaldehyde (4.88 g, 38.80 mmol) and
diketene (5.36 mL, 69.60 mmol) in CH2Cl2 (104 mL) at −78 °C.
After 5 minutes, methanol (6.24 mL, 154.0 mmol) was added
and the mixture was stirred at −20 to −10 °C for 1.5 hours.
The reaction mixture was diluted with Et2O (100.0 mL) and a
20% w/v citric acid solution (120.0 mL) was added. The layers
were separated and the aqueous layer was extracted with Et2O
(2 × 50 mL). The combined organic extracts were washed with
brine (2 × 50 mL), dried over MgSO4 and concentrated
in vacuo. Flash column chromatography (hexane–ethyl acetate,
3 : 2) gave the product as an oil, isolated yield 7.33 g (76%).
ν max/cm−1 (film) 3423, 3026, 2953, 1740, 1710, 1436, 1319,
1266, 1149, 1070, 967, 747, 694 cm−1; 1H NMR (400 MHz,
CDCl3): δ 7.28–7.05 (5H, m), 6.57 (1H, d, J = 16.0 Hz), (1H, dd,
J = 16.0, 5.4 Hz), 4.62 (1H, m), 3.30 (3H, s), 3.10 (2H, s), 2.49
(1H, dd, J = 16.8, 8.9 Hz), 2.31 (1H, dd, J = 16.8, 3.6 Hz) ppm;
δC (100 MHz, CDCl3): 201.9, 167.3, 137.2, 131.0, 130.2, 128.8,
127.8, 126.8, 68.4, 51.8, 49.7 and 49.6 ppm; m/z (ESI+) 271
(M + Na)+. (Found 271.0937 (M + Na)+. C14H16NaO4 requires
271.0941).
(2S*,4S*,6S*)-2-Phenyl-6-((E)-styryl)tetrahydro-2H-pyran-4-ol
14. A solution of 8f (0.059 g, 0.175 mmol) in DMF (0.92 mL)
and H2O (0.02 mL) was submitted to 200 W microwave radi-
ation in a sealed tube at 160 °C for 10 minutes. The solution
was cooled to rt and taken up in EtOAc (30.0 mL). The mixture
was washed with H2O (2 × 20.0 mL). The aqueous layer was
extracted with EtOAc (30.0 mL) and the combined organic
extracts were washed with brine (20.0 mL), dried over MgSO4
and concentrated in vacuo to give 0.044 g (91%) of a dark
yellow oil. ν max/cm−1 (film) 2978, 2881, 1721, 1230, 1047,
966, 753, 737, 695 cm−1; δH (400 MHz, CDCl3) 7.34–7.17 (10H,
m), 6.53 (1H, dd, J = 16.3, 1.3 Hz), 6.23 (1H, dd, J = 16.3, 5.1
Hz), 5.12 (1H, dd, J = 7.7, 4.8 Hz), 4.82 (1H, ddd, J = 10.5, 5.2,
5.1 Hz), 2.78–2.68 (4H, m) ppm; NOE H2 – H3α 1.33%, H2 –
H3β 1.89%, H4 – H6 1.23%, H4 – H3α 1.58%, H4 – H5α 2.59%;
δC (100 MHz, CDCl3) 205.9, 140.5, 135.7, 133.5, 128.8, 128.7,
128.3, 128.2, 127.9, 126.7, 126.5, 73.6, 72.9, 47.8, 45.4 ppm;
m/z (ESI+) 301 (M + Na)+. (Found 301.1196 (M + Na)+.
C19H18NaO2 requires 301.1199). A 1.0 M solution of L-Selec-
tride® in THF (0.73 mL) was added to a stirred solution of the
crude decarboxylated product (0.079 g, 0.28 mmol) in THF
(3.5 mL) at −78 °C. The mixture was stirred at this temperature
for 15 minutes then warmed to room temperature. Upon com-
pletion, the mixture was diluted with Et2O (20.0 mL) and sat.
aq. NH4Cl (20.0 mL) and the layers separated. The aqueous
layer was washed with Et2O (20.0 mL) and the combined
organic extracts were washed with brine (20.0 mL), dried over
MgSO4 and concentrated in vacuo to give 14 as a light yellow
oil, 0.052 g (66%), dr 9 : 1. ν max/cm−1 (film) 3374, 2925, 1448,
1364, 1052, 695 cm−1; δH (400 MHz, CDCl3) 7.47–7.22 (10H,
m), 6.64 (1H, dd, J = 16.1, 1.1 Hz), 6.37 (1H, dd, J = 16.1,
5.8 Hz), 5.31 (1H, t, J = 4.4 Hz), 4.98 (1H, m, minor), 4.74 (1H,
m, minor), 4.27 (1H, dddd, J = 9.1, 5.8, 5.0, 1.1 Hz), 4.19 (1H, m,
minor), 4.07 (1H, dddd, J = 9.3, 9.0, 4.5, 4.0 Hz), 2.54 (1H, ddd,
J = 13.5, 4.4, 4.0 Hz), 2.31 (1H, m, minor), 2.19 (1H, m, minor),
2.08 (1H, ddd, J = 12.6, 5.0, 4.5 Hz), 1.96 (1H, ddd, J = 13.5, 9.0,
4.4 Hz), 1.89 (1H, m, minor), 1.64 (1H, ddd, J = 12.6, 9.3, 9.1 Hz)
and 1.64 (1H, bs) ppm; δC (100 MHz, CDCl3) 140.7, 136.8,
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130.6, 129.9, 128.8, 128.7, 127.8, 127.3, 126.6, 126.4, 72.2, 70.6,
64.7, 40.5 and 37.0 ppm; m/z (ESI+) 303 (M + Na)+. (Found
303.1361 (M + Na)+. C19H20NaO2 requires 303.1356). Data in
agreement with that previously reported.19f
2-((2S*,4S*,6S*)-4-(Methoxymethoxy)-6-phenyltetrahydro-2H-
pyran-2-yl)-1-phenylethanone 15. N,N-Diisopropylethylamine
(0.6 mL, 3.36 mmol), MOMCl (0.34 mL, 4.48 mmol) and
sodium iodide (0.1 g, 0.67 mmol) were added to a stirred solu-
tion of 14 (0.078 g, 0.28 mmol) in THF (5.0 mL) at room temp-
erature. The mixture was heated at 50 °C for 10 hours, after
which the solvent was removed in vacuo., the reaction mixture
was diluted with H2O (20 mL) and extracted with EtOAc
(20 mL). The extract was washed with brine and dried over
MgSO4 and concentrated in vacuo to give the product 0.054 g
(60%) as a light yellow oil. ν max/cm−1 (film) 2923, 2854, 1145,
1033, 695 cm−1; δH (400 MHz, CDCl3) 7.47–7.22 (10H, m), 6.62
(1H, d, J = 16.0 Hz), 6.38 (1H, dd, J = 16.0, 6.0 Hz), 5.29 (1H, t,
J = 4.4 Hz), 4.74, (2H, s), 4.26 (1H, dddd, J = 9.2, 6.0, 4.6, 1.2
Hz), 3.96 (1H, dddd, J = 9.4, 9.2, 5.0, 4.0 Hz), 3.41, (3H, s), 2.54
(1H, dddd, J = 13.4, 4.4, 4.0, 1.5 Hz), 2.09 (1H, ddd, J = 12.8,
5.0, 4.6, 1.5 Hz), 2.03 (1H, ddd, J = 13.4, 9.4, 4.4 Hz), 1.67 (1H,
ddd, J = 12.8, 9.2, 9.2 Hz) ppm; δC (100 MHz, CDCl3) 140.6,
136.9, 130.5, 129.9, 128.7, 128.6, 127.7, 127.3, 126.6, 126.4,
94.9, 72.3, 70.8, 69.8, 55.4, 37.9 and 34.6 ppm; m/z (ESI+) 347
(M + Na)+. (Found 347.1618 (M + Na)+. C21H24NaO3 requires
347.1618).
PdCl2 (0.004 g, 0.02 mmol) and CuCl (0.006 g, 0.06 mmol)
were added to a stirred solution of crude MOM-protected
alcohol (0.014 g, 0.04 mmol) in DMF (0.5 mL) and H2O
(0.5 mL) at room temperature. The mixture was heated at 50 °C
for 3 days under an oxygen atmosphere, after which the
solvent was removed in vacuo to give 15 0.010 g (70%) as a
light yellow oil. ν max/cm−1 (film) 2921, 1682, 1445, 1036,
690 cm−1; δH (400 MHz, CDCl3) 7.97 (2H, dd, J = 7.0, 1.0 Hz),
7.57 (1H, tt, J = 7.4, 1.2 Hz), 7.47 (2H, t, J = 7.3 Hz), 7.35–7.29
(5H, m), 5.16 (1H, t, J = 4.3 Hz), 4.70 (2H, s), 4.24 (1H, dddd,
J = 9.3, 7.0, 5.9, 3.0 Hz), 3.91 (1H, dddd, J = 9.8, 9.3, 4.2, 4.1 Hz),
3.42 (1H, dd, J = 15.9, 7.0 Hz), 3.38, (3H, s), 3.18 (1H, dd, J =
15.9, 5.9 Hz), 2.52 (1H, ddd, J = 13.5, 4.3, 4.1 Hz), 2.08 (1H,
ddd, J = 12.6, 4.2, 3.0 Hz), 1.98 (1H, ddd, J = 13.5, 9.8, 4.3 Hz),
1.67 (1H, ddd, J = 12.6, 9.3, 9.3 Hz) ppm; δC (100 MHz, CDCl3)
198.1, 140.4, 137.2, 133.2, 128.7, 128.3, 127.2, 126.4, 95.2, 72.4,
69.5, 67.5, 55.4, 44.4, 38.1, 34.7 and 30.0 ppm; m/z (ESI+) 363
(M + Na)+. (Found 363.1559 (M + Na)+. C21H24NaO4 requires
363.1567). Data in agreement with those previously reported.19f
Diospongin B 2
A solution of THP 15 (0.013 mg, 0.04 mmol) and 30% HCl
(0.68 mL) was stirred in THF (2.1 mL) at room temperature for
2 hours, after which water was added and the mixture neutral-
ized with NaHCO3 before being extracted with EtOAc
(30.0 mL). The organic extract was washed with H2O (20.0 mL),
dried over MgSO4 and concentrated in vacuo to give diospon-
gin B, 0.006 g (58%) as a light yellow oil. ν max/cm−1 (film)
3375, 2916, 2846, 1557, 1411, 1129 cm−1; δH (400 MHz,
CDCl3)) 7.98 (2H, dd, J = 8.0, 1.7 Hz), 7.58 (1H, tt, J = 7.1,
1.3 Hz), 7.47 (2H, td, J = 7.6, 2.2 Hz), 7.37–7.3 (5H, m), 5.19
(1H, t, J = 4.3 Hz), 4.23 (1H, dddd, J = 9.5, 7.1, 6.0, 3.0 Hz), 4.03
(1H, dddd, J = 9.9, 9.5, 5.5, 4.5 Hz), 3.46 (1H, dd, J = 15.8,
7.1 Hz), 3.18 (1H, dd, J = 15.8, 6.0 Hz), 2.52 (1H, ddd, J = 13.4,
5.5, 4.3 Hz), 2.06 (1H, ddd, J = 12.4, 4.5, 3.0 Hz), 1.92 (1H, ddd,
J = 13.4, 9.9, 4.3 Hz), 1.51 (1H, ddd, J = 12.4, 9.5, 9.5 Hz) ppm;
δC (100 MHz, CDCl3) 198.5, 140.4, 137.2, 133.3, 128.7, 128.6,
128.4, 127.2, 126.4, 72.5, 67.0, 64.3, 44.7, 40.3 and 36.8 ppm;
m/z (ESI+) 319 (M + Na)+. (Found 319.1300 (M + Na)+.
C19H20NaO3 requires 319.1305). Data in agreement with those
previously reported.19
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